Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2023-03-21 00:00:00 ET · period of report 2023-03-17 · accession 0001209191-23-020244 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-03-21 | 2023-03-17 | VRTX | WAGNER CHARLES F JR | EVP, CFO | S - Sale | $296.39 | -2,000 | 51.6K | -4% | -$592.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-17 | S | D | 784 | $295.43 | 52,235 | D | — | — | (F2) Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F4) Open market sales reported on this line occurred at a weighted average price of $295.43 (range $295.09 to $295.97). |
| 2 | Common | Common Stock | 2023-03-17 | S | D | 240 | $296.30 | 51,995 | D | — | — | (F2) Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F5) Open market sales reported on this line occurred at a weighted average price of $296.30 (range $296.14 to $296.45). |
| 3 | Common | Common Stock | 2023-03-17 | S | D | 240 | $299.58 | 51,395 | D | — | — | (F2) Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F7) Open market sales reported on this line occurred at a weighted average price of $299.58 (range $299.09 to $300.06). |
| 4 | Common | Common Stock | 2023-03-17 | S | D | 16 | $301.13 | 51,379 | D | — | — | |
| 5 | Common | Common Stock | 2023-03-17 | S | D | 360 | $294.52 | 53,019 | D | — | — | (F2) Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F3) Open market sales reported on this line occurred at a weighted average price of $294.52 (range $293.98 to $294.81). |
| 6 | Common | Common Stock | 2023-03-17 | S | D | 360 | $298.09 | 51,635 | D | — | — | (F2) Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F6) Open market sales reported on this line occurred at a weighted average price of $298.09 (range $297.65 to $298.48). |